Tolmar - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsTolmar

Tolmar

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Eligard	Leuprolide	2002-01-23	2023-2041	Breast neoplasms , Endometrial neoplasms , Endometriosis , Infertility , Leiomyoma , Ovarian neoplasms , Precocious puberty , Prostatic hyperplasia , Prostatic neoplasms
Fensolvi	Leuprolide	2020-05-01	2023-2041	Breast neoplasms , Endometrial neoplasms , Endometriosis , Infertility , Leiomyoma , Ovarian neoplasms , Precocious puberty , Prostatic hyperplasia , Prostatic neoplasms
Jatenzo	Testosterone undecanoate	2019-03-27	2026-2041	Psychological sexual dysfunctions , Breast neoplasms , Delayed puberty , Hypogonadism
Ketoconazole	Ketoconazole	2005-04-11		Cushing syndrome, Acanthamoeba keratitis, Blastomycosis, Chronic mucocutaneous candidiasis, Coccidioidomycosis, Cutaneous candidiasis, Histoplasmosis, Leishmaniasis, Mycoses, Oral candidiasis, Paracoccidioidomycosis, Seborrheic dermatitis, Tinea pedis, Tinea versicolor, Vulvovaginal candidiasis
Levetiracetam	Levetiracetam	2009-01-15	2026-2034	Epilepsy, Juvenile myoclonic epilepsy, Partial epilepsies, Tonic-clonic epilepsy
Ranitidine	Ranitidine	2010-11-15		Duodenal ulcer, Gastroesophageal reflux, Peptic esophagitis, Stomach ulcer, Zollinger-ellison syndrome

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

breast neoplasms

,

precocious puberty

Microcrystalline cellulose

breast neoplasms

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use